In an attempt to increase the safety profile of IFN-α, a mutant was developed with a greater dissociation rate from its receptor, and it resulted in enhanced tumor-specific lysis while sparing healthy cells compared to the wild type [140,141]. Here, IFNA2 is linked to neoplasm.